In the present study, we attempted to design and synthesize some novel dual acting 3-benzyl-5-benzylidene-thiazolidine-2,4-dione derivatives possessing antihyperglycemic as well as aldose reductase inhibitory action. The designed compounds were docked on different X-ray crystal structures of human aldose reductase 2 (ALR2) and peroxisome proliferator-activated receptor γ (PPARγ). The antihyperglycemic action of the compounds was evaluated using sucrose loaded model (SLM) and alloxan induced diabetic model (AIDM). Some of the synthesized compound demonstrated antihyperglycemic action better than that of metformin and also scores well when docked on different X-ray crystal structures of human ALR2 and were expected to be dual acting.
You may also start an advanced similarity search for this article.